Skip to main content
Clinical Trials/CTRI/2021/12/038901
CTRI/2021/12/038901
Not yet recruiting
Phase 2

A clinical trial to evaluate the efficacy of oral administration of Clitoria ternatea Linn. powder and Saraswata Ghrita Nasya in the management of Autism Spectrum Disorder in paediatric population. - Autism spectrum disorder, Saraswata Ghrita, Nasya, Ayurveda

All India Institute of Ayurveda0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: F840- Autistic disorder
Sponsor
All India Institute of Ayurveda
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • Children between 2\-12 years of age, either of gender, fulfilling the screening criteria of Autism Spectrum Disorder and Parents/Guardian are willing to give informed written consent to participate, will be included in the study.

Exclusion Criteria

  • Children with chronic systemic illnesses or taking anti\-epileptic or anti\-psychotic drugs or Parents/Guardian not willing to give informed written consent to participate, will be excluded from the study.

Outcomes

Primary Outcomes

Not specified

Similar Trials